Bracknell, United Kingdom

Brian Kenneth Snell

This inventor holds 1 USPTO granted patent. Top assignee: Imperial Chemical Industries Limited. Active years: 1976.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 1976

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Brian Kenneth Snell: Innovator in Plant Disease Combat

Introduction

Brian Kenneth Snell is a notable inventor based in Bracknell, GB. He has made significant contributions to the field of organic chemistry, particularly in developing compounds that are useful in combating plant diseases. His innovative work has led to the creation of a patent that addresses critical agricultural challenges.

Latest Patents

Brian Kenneth Snell holds a patent for organic compounds and compositions containing 2-Ethylamino-4-methyl-5-n-butyl-6-hydroxypyrimidine and salts thereof. This invention is particularly valuable in the fight against plant diseases, showcasing his commitment to improving agricultural practices.

Career Highlights

Throughout his career, Snell has been associated with Imperial Chemical Industries Limited, a company known for its advancements in chemical manufacturing and innovation. His work at this esteemed organization has allowed him to focus on developing solutions that benefit both the agricultural sector and the environment.

Collaborations

Some of his notable coworkers include Richard Stewart Elias and Peter Frank Freeman. Their collaborative efforts have contributed to the success of various projects within the company, enhancing the impact of their innovations.

Conclusion

Brian Kenneth Snell's contributions to organic chemistry and plant disease management highlight his role as an influential inventor. His patent and work at Imperial Chemical Industries Limited reflect his dedication to advancing agricultural science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…